Ensign Peak Advisors, Inc Black Diamond Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$22.23 - $34.75 $709,070 - $1.11 Million
-31,897 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$29.47 - $35.0 $216,633 - $257,285
7,351 Added 29.95%
31,897 $1.02 Million
Q3 2020

Nov 12, 2020
BUY
$26.17 - $43.07 $616,198 - $1.01 Million
23,546 Added 2354.6%
24,546 $742,000
Q1 2020

May 11, 2020
BUY
$18.18 - $39.48 $18,180 - $39,480
1,000 New
1,000 $25,000

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $77.8M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email